GLP-1 Tirzepatide ReviewS.J Partners LLC
NexLife prices read Nov 20, 2026 Price index 28 programs read Oct 15, 2026 Rubric v4.1 Corrections open log

Pillar / Money

Tirzepatide Cost Without Insurance

Direct answer

Without insurance, the cheapest FDA-approved route is $149 a month for the Foundayo or Wegovy pill at starting doses, and brand Zepbound vials cost $299 to $449 a month at LillyDirect by dose. Compounded tirzepatide runs $69 to $299 a month all-in across the 28 programs in our November 20, 2026 index, median $144.

Answer last reviewed:

Current prices, read October 15 and November 20, 2026

Market check, November 20, 2026: 28 compounded tirzepatide programs in our index run from $69 (a Black Friday sale price) to $299 a month all-in, median $144; 28 compounded semaglutide programs run $39 to $249, median $114. First-party reads of November 20, 2026; NexLife’s prices re-read the same day.

Compounded tirzepatide, lowest all-in monthly figure per program, sorted low to high. 28 programs; first-party reads of October 15, 2026, NexLife November 20, 2026. Membership counted (annual fee ÷ 12).
ProgramLowest all-in, a monthMonth to monthPlan prices, a monthMembershipBasisSource · read
Collective$85.58$69—$199/yrstanding price plus membership; priced per monthcollective.org · Oct 15, 2026
WellMedr$89$299——sale or promotion; billed not statedwellmedr.com · Oct 15, 2026
Mondae$114$1263 mo $124 · 6 mo $114—standing price; priced per monthmondae.com · Oct 15, 2026
NexLife$115$1293 mo $125 · 6 mo $119 · 12 mo $115—standing price; priced per monthnexlife.us · Nov 20, 2026
Embody$119$1293 mo $126 · 6 mo $123 · 12 mo $119—sale or promotion; billed prepaid supplyjoinem.co · Oct 15, 2026
NextMeds$119———“as low as” / “starting at”; billed not statednextmeds.com · Oct 15, 2026
SnagRx$119$119——sale or promotion; priced per monthsnagrx.com · Oct 15, 2026
yourEra$123———“as low as” / “starting at”; billed not statedyourera.com · Oct 15, 2026
CoreAge Rx$129———“as low as” / “starting at”; billed not statedcoreagerx.com · Oct 15, 2026
Eden$129$129——standing price; priced per montheden.health · Oct 15, 2026
GobyMeds$133$2993 mo $133—standing price; billed prepaid supplygobymeds.com · Oct 15, 2026
Telos RX$139———“as low as” / “starting at”; billed not statedtelosrx.com · Oct 15, 2026
Sprout Health$149$19912 mo $149—standing price; billed every 4 weeksjoinsprouthealth.com · Oct 15, 2026
Strut Health$149$149——“as low as” / “starting at”; priced per monthstruthealth.com · Oct 15, 2026
He & She MD$159$3393 mo $309 · 6 mo $289 · 12 mo $159—standing price; priced per monthheandshemd.com · Oct 15, 2026
Bodybuilding Health+$174.67$2093 mo $179 · 6 mo $174.67 · 12 mo $187.33—standing price; billed term not statedbbhealthplus.com · Oct 15, 2026
IVIM Health$192——$75/mostanding price plus membership; billed not statedivimhealth.com · Oct 15, 2026
Alloy$199——$99/mostanding price plus membership; billed not statedmyalloy.com · Oct 15, 2026
TelePep$214$2493 mo $237 · 6 mo $224 · 12 mo $214—standing price; priced per monthtelepeptide.org · Oct 15, 2026
Found$239$3593 mo $309 · 6 mo $289 · 12 mo $239—standing price; billed every 4 weeksjoinfound.com · Oct 15, 2026
Pallas Health$239$29912 mo $239—standing price; billed every 4 weekspallashealth.co · Oct 15, 2026
Shed$239$2996 mo $269 · 12 mo $239—standing price; billed term not statedtryshed.com · Oct 15, 2026
Enhance.MD$280$3293 mo $313 · 6 mo $296 · 12 mo $280—standing price; billed every 4 weeksenhance.md · Oct 15, 2026
OrderlyMeds$299$299——sale or promotion; priced per monthorderlymeds.com · Oct 15, 2026

Start with the manufacturer, not a platform

The single most expensive mistake in self-pay GLP-1 purchasing is buying a brand-name drug through a telehealth platform that resells it near retail. Our dataset contains brand Wegovy at $1,794 a month all-in from one provider and brand Mounjaro at $2,048 from another. NovoCare sells Wegovy direct for $349. Lilly runs no self-pay programme for Mounjaro, but Zepbound is the same molecule at $299 to $449.

That is a four to twelvefold difference for the identical medicine, and it is disclosed pricing rather than fraud. Price any brand drug at LillyDirect or NovoCare before buying it anywhere else.

The self-pay ladder in 2026

$86–$126 — the low end of compounded tirzepatide in our October 15, 2026 index (Collective with its membership, WellMedr on a sale, Mondae). NexLife lists $115 to $129 a month (November 20, 2026). Not FDA-approved.

$149 — FDA-approved oral orforglipron or oral Wegovy tablets, at starting doses. Reviewed for safety, effectiveness and quality.

$133–$214 — the middle of the compounded tirzepatide index (October 15, 2026 reads).

$299–$449 — brand Zepbound direct from LillyDirect, by dose tier.

$278–$399 — the upper band of compounded programmes, which overlaps the brand band.

Where self-pay logic breaks down

The overlap in that ladder is the finding. A compounded programme at $349 costs more than the approved injectable at $299 and more than twice the approved oral. Whatever the argument for compounded medicine is at that price, it is not a cost argument.

The cost argument holds firmly at the bottom of the range, and it holds for flat-rate programmes at maintenance doses, where a dose-independent price beats a brand tier that rises to $449.

Before you conclude you have no coverage

Three checks are worth the twenty minutes, because any of them beats every self-pay figure above.

  1. Check your plan's formulary directly for Zepbound and Wegovy, and check whether the exclusion is for weight management specifically. Coverage for a diabetes indication is often separate.
  2. Ask about prior authorisation criteria. Many plans cover with documentation of BMI and comorbidities.
  3. Check manufacturer savings programmes, which are separate from the self-pay pricing above and have their own eligibility rules.

Where a commercial plan covers either brand, the cost can fall to roughly $25 a month. No self-pay route competes with that, and no compounded programme comes close.

Mean weight reduction by drug and dose, from the trials that produced each figureSeparate trials, different durations and populations
Tirzepatide 15 mg (SURMOUNT-1)21%Oral semaglutide 25 mg, adherent (17%Injectable semaglutide 2.4 mg (SUR14%Oral semaglutide 25 mg, treatment-14%Orforglipron 17.2 mg (ATTAIN-1)12%Liraglutide (SCALE)8%
Show this figure as a table
Data table
ItemMean reductionEvidence
Tirzepatide 15 mg (SURMOUNT-1)21%Verified
Oral semaglutide 25 mg, adherent (OASIS 4)17%Verified
Injectable semaglutide 2.4 mg (SURMOUNT-5)14%Verified
Oral semaglutide 25 mg, treatment-policy (OASIS 4)14%Verified
Orforglipron 17.2 mg (ATTAIN-1)12%Provider-reported
Liraglutide (SCALE)8%Provider-reported
These come from different trials and are not a head-to-head comparison. Durations differ (64 to 72 weeks) and estimands differ. Only SURMOUNT-5 compared two of these drugs directly.
Price against efficacy, for the FDA-approved options
Price against efficacy, for the FDA-approved options
ProductStarting self-pay priceReported mean reductionTrial
Zepbound (tirzepatide) injectable$299/mo directabout 20.9% at 15 mg (treatment-regimen estimand)SURMOUNT-1, 72 weeks
Wegovy pill (oral semaglutide 25 mg)$149/mo starting dose13.6–16.6% depending on estimandOASIS 4, 64 weeks
Wegovy injectable (semaglutide 2.4 mg)$349/mo maintenanceabout 13.7%SURMOUNT-5, 72 weeks
Foundayo (orforglipron)$149/mo starting doseabout 11–12.4% at 17.2 mgATTAIN-1, 72 weeks
Both $149 products are the least effective approved options in this table. That does not make them bad choices — it makes a price comparison that omits efficacy an incomplete one.
Where NexLife actually ranksas of November 9, 2026

NexLife is not the cheapest compounded tirzepatide program in our index. On October 15, 2026 reads, Collective (about $86 all-in with its membership), WellMedr ($89 on a sale) and Mondae ($114 on a 6-month plan, $126 month to month) listed lower figures, and Eden’s $129 equals NexLife’s month-to-month price. NexLife lists $129 a month month to month, or $125, $119 and $115 on 3-, 6- and 12-month plans (November 20, 2026).

What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife charges the same at every covered dose, with no membership fee.

Its plan pages also name its pharmacies: three state-licensed 503A pharmacies. Every other figure on this site carries its own source and read date.

See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.

Starting price, maintenance price, twelve-month totalTirzepatide programmes, ordered by advertised price
Starting price, maintenance price, twelve-month total
Provider and programmeAdvertised monthlyAt 10 mgTwelve monthsDose structure
Embody — compounded injectable$99not verifiednot verifiednot verified
SkinnyRx — compounded injectable$129not verifiednot verifiednot verified
Lavender Sky Health — compounded injectable$129not verifiednot verifiednot verified
Fifty 410 — compounded injectable$133not verifiednot verifiednot verified
Yucca Health — compounded injectable$146not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded microdose$115not verifiednot verifiednot verified
Found — compounded injectable$169not verifiednot verifiednot verified
Enhance.MD — compounded microdose$169not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded injectable$115not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded microdose$129$129 Verification pending$1,548 Verification pendingFlat at every dose Provider-reported
NexLife (opens nexlife.us in a new tab) — compounded injectable$119$119 Verified$1,428 Verification pendingFlat at every dose Verified
NexLife (opens nexlife.us in a new tab) — compounded injectable$125$125 Verified$1,500 Verification pendingFlat at every dose Verified
Oak Longevity — compounded injectable$199not verifiednot verifiednot verified
Shed — compounded microdose$199not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded oral / ODT$199not verifiednot verifiednot verified
NexLife — compounded injectable$129$129 Verified$1,548 Verification pendingFlat at every dose Verified
Blank cells in the maintenance and annual columns mean the provider does not publish an escalation ladder, so we cannot compute what treatment actually costs. That gap is the finding, not an omission on our part.
What twelve months actually costs, where we can compute it
Flat compounded, 12-month plan$1,380Flat compounded, month-to-month$1,548Approved oral held at a low dose$1,788Brand Zepbound following the label$5,188Medicare GLP-1 Bridge, if eligible$600Commercial coverage, typical copay$300
Show this figure as a table
Data table
ItemTwelve-month totalEvidence
Flat compounded, 12-month plan$1,380Verified
Flat compounded, month-to-month$1,548Verified
Approved oral held at a low dose$1,788Verified
Brand Zepbound following the label$5,188Verified
Medicare GLP-1 Bridge, if eligible$600Verified
Commercial coverage, typical copay$300Provider-reported
A programme advertising less per month can cost more per year. Coverage beats every self-pay route by an order of magnitude.
The four routes, monthly
FDA-approved oral, starterOrforglipron $149Oral Wegovy $149FDA-approved injectable, direcZepbound 2.5mg $299Zepbound 7.5-15mg $449Compounded, lower bandTirzepatide $169Semaglutide $133Compounded, upper bandTirzepatide $399Semaglutide $299Brand resold near retailWegovy via platform $1,794Mounjaro via platform $2,048OrforglipronOral Wegovy
Show this figure as a table
Data table
ItemOrforglipronOral Wegovy
FDA-approved oral, starter$149$149
FDA-approved injectable, direct$299$449
Compounded, lower band$169$133
Compounded, upper band$399$299
Brand resold near retail$1,794$2,048
The bottom row is the same medicine the manufacturers sell direct for $349 and $299-$449 respectively.
What an all-in price is made of
Medication—Membership—Shipping—Dose surcharge—Consultation—Labs—Structure only. No widths are proportional to anything, because nothing is captured.
Show this figure as a table
Data table
ComponentAmount
Medicationnot captured
Membershipnot captured
Shippingnot captured
Dose surchargenot captured
Consultationnot captured
Labsnot captured
All-in totalnot captured
A provider that advertises only the first segment is quoting a price you cannot actually pay.
Where a headline price usually stops short
Where a headline price usually stops short
Cost componentInside the advertised figure?Charged anyway?
Medicationyesyes
Membership or program feenonot verified
Shippingnonot verified
Higher-dose surchargenonot verified
Initial consultationnonot verified
Required laboratory worknonot verified
Cancellation or restocking termsnonot verified
The right-hand column fills in per provider as capture proceeds. Until then it reads unverified, which is the honest state.
Approved product against compounded preparation
Approved product against compounded preparation
AttributeFDA-approved tirzepatide (Zepbound, Mounjaro)Compounded tirzepatide
Regulatory statusApproved finished drug productNot an FDA-approved product
Generic equivalentNo generic tirzepatide existsNot a generic and not therapeutically equivalent
Manufacturing standardManufactured under CGMPDepends on the compounder's registration class
Clinical trial evidenceStudied in the registration trialsTrials studied the approved product, not this preparation
LabellingFDA-approved labellingSupplied by the compounder
PresentationManufacturer's pens or vialsVaries; multi-dose vials add a measuring step
Independent price verificationnot verifiednot verified
No provider may describe a compounded preparation as FDA-approved or as generic Zepbound. Both statements are false, and both are common.
Pricing at a glanceas of 2026-07-24

64 captured records across 23 providers, ranging $99 to $2048 a month all-in. 9 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.

Open the full price index · CSV · JSON

Take the data with youCC BY 4.0 with attribution

Pricing dataset, CSV · Pricing dataset, JSON

Suggested citation: GLP-1 Tirzepatide Review, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.

Questions readers actually ask

What is the cheapest way to get tirzepatide without insurance?

For the approved drug, LillyDirect at $299 for the starter vial. For the cheapest approved GLP-1 of any kind, orforglipron or oral Wegovy tablets at $149. Compounded programmes start lower but are not FDA-approved.

Should I buy brand drugs through a telehealth platform?

Price it at the manufacturer first. Some platforms resell brand drugs at four to twelve times the manufacturer's own direct self-pay price.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “Tirzepatide Cost Without Insurance.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/tirzepatide-cost-without-insurance/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Report an error
Comparing 0 of 4